|
RAPGEF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.87920000022702E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.83404419324052E-12 |
| Normal-vs-Stage2 |
1.982370E-02 |
| Normal-vs-Stage3 |
8.516000E-01 |
| Normal-vs-Stage4 |
6.098600E-01 |
| Stage1-vs-Stage2 |
1.574800E-01 |
| Stage1-vs-Stage3 |
2.57379995094453E-09 |
| Stage1-vs-Stage4 |
4.28200000013312E-07 |
| Stage2-vs-Stage3 |
3.264200E-02 |
| Stage2-vs-Stage4 |
1.495910E-02 |
| Stage3-vs-Stage4 |
5.357000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.341900000007E-06 |
| Normal-vs-AfricanAmerican |
3.573800E-02 |
| Normal-vs-Asian |
4.095800E-01 |
| Caucasian-vs-AfricanAmerican |
9.309000E-01 |
| Caucasian-vs-Asian |
8.528400E-01 |
| AfricanAmerican-vs-Asian |
9.002000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.401170E-03 |
| Normal-vs-Female |
3.34059999662628E-08 |
| Male-vs-Female |
6.296800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.742380E-01 |
| Normal-vs-Age(41-60Yrs) |
2.36899999950246E-07 |
| Normal-vs-Age(61-80Yrs) |
3.096400E-03 |
| Normal-vs-Age(81-100Yrs) |
4.612200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.930000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.458000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.811400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.897940E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.952780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.548000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.260770E-03 |
| Normal-vs-Grade 2 |
2.07609485158855E-11 |
| Normal-vs-Grade 3 |
5.260000E-02 |
| Normal-vs-Grade 4 |
1.197180E-01 |
| Grade 1-vs-Grade 2 |
1.713980E-02 |
| Grade 1-vs-Grade 3 |
3.063000E-03 |
| Grade 1-vs-Grade 4 |
5.42450000029504E-07 |
| Grade 2-vs-Grade 3 |
5.18280000028071E-07 |
| Grade 2-vs-Grade 4 |
1.80060000243287E-08 |
| Grade 3-vs-Grade 4 |
3.700500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62458935193399E-12 |
| Normal-vs-ccB subtype |
5.886000E-01 |
| ccA subtype-vs-ccB subtype |
2.28017604797515E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.89079999999687E-05 |
| Normal-vs-N1 |
2.251400E-01 |
| N0-vs-N1 |
2.490500E-02 |
|
|
